MEDIZONE INTERNATIONAL INC
NT 10-Q, 1998-11-16
DRUGS, PROPRIETARIES & DRUGGISTS' SUNDRIES
Previous: CARLINVILLE NATIONAL BANK SHARES INC/DE, 10-Q, 1998-11-16
Next: SANDS REGENT, 10-Q, 1998-11-16



                            UNITED STATES
                 SECURITIES AND EXCHANGE COMMISSION
                        Washington, D.C.  20549

                              FORM 12b-25
                       NOTIFICATION OF LATE FILING

(Check one): ___ Form 10-KSB __ Form 20-F  X Form 10-QSB __ Form N-SAR
                                          ---
            For period ended: September 30, 1998

            [ ] Transition Report on Form 10-K and Form 10-KSB
            [ ] Transition Report on Form 20-F
            [ ] Transition Report on Form 11-K
            [ ] Transition Report on Form 10-Q and Form 10-QSB
            [ ] Transition Report on Form N-SAR
            For the transition period ended                                 
     

SEC File Number 2-93277-D

CUSIP Number - 58501310

Nothing in this form shall be construed to imply that the Commission has
verified any information contained herein.

If the notification relates to a portion of the filing checked above,
identify the item(s) to which the notification 
relates:_________________________________________

PART I-REGISTRANT INFORMATION

MEDIZONE INTERNATIONAL, INC.
- --------------------------------------
Full Name of Registrant

144 Buena Vista
Stinson Beach, CA  94970
(415) 868-0300
- --------------------------------------
Address and telephone number of
principal executive office

PART II-RULES 12b-25(b) AND (c)

If the subject report could not be filed without unreasonable effort or
expense and the registrant seeks relief pursuant to Rule 12b-25(b), the
following should be completed. (Check appropriate box)

[X]   (a)   The reasons described in reasonable detail in Part III of this
            form could not be eliminated without unreasonable effort or 
            expense;

[X]   (b)   The subject annual report, semi-annual report, transition report
            on Forms 10-K, 10-KSB, 20-F, 11-K, or Form N-SAR, or portion
            thereof will be filed on or before the 15th calendar day
            following the prescribed due date; or the subject quarterly
            report or transition report on Form 10-Q, 10-QSB, or portion
            thereof will be filed on or before the fifth calendar day
            following the prescribed due date; and

[ ]   (c)   The accountant's statement or other exhibit required by Rule
            12b-25(c) has been attached if applicable.


PART III-NARRATIVE

      State below in reasonable detail the reasons why the Form 10-K,
10-KSB, 11-K, 20-F 10-Q, 10-QSB, N-SAR or the transition report portion
thereof, could not be filed within the prescribed time period.

      The quarterly report of the registrant on Form 10-QSB could not be
      filed because management requires additional time to compile and
      verify the data required to be included in the report.  This delay was
      the result of a change of chief financial officers and bookkeeping
      personnel following the end of the quarter.  The transition to the new
      chief financial officer and related bookkeeping personnel was hindered
      by a delay in delivery of the financial records and documentation by 
      the former CFO.

PART IV-OTHER INFORMATION

(1)   Name and telephone number of person to contact in regard to this 
      notification.

   Kevin R. Andersen              (801)             486-0096                
                                 
        (Name)                 (Area Code)    (Telephone Number)

(2)   Have all other periodic reports required under Section 13 or 15(d) or
      the Securities Exchange Act of 1934 or Section 30 of the Investment
      Company Act of 1940 during the preceding 12 months (or for such
      shorter period that the registrant was required to file such
      report(s)) been filed?  If the answer is no, identify report(s).
                                                           X  Yes    __ No
                                                          ---
 
(3)   Is it anticipated that any significant change in results of operations
      from the corresponding period for the last fiscal year will be
      reflected by the earnings statements to be included in the subject
      report or portion thereof?

                                                          __ Yes       X  No
                                                                      ---

            If so:  attach an explanation of the anticipated change, both
            narratively and quantitatively, and, if appropriate, state the
            reasons why a reasonable estimate of the results cannot be made.









                                      2
<PAGE>

                         MEDIZONE INTERNATIONAL, INC.                       
                         ----------------------------  
                  (Name of Registrant as Specified in Charter)

has caused this notification to be signed on its behalf by the undersigned
thereunto duly authorized.



Date   November 13, 1998        By:  /s/ Edwin G. Marshall
                                   ----------------------------
                                      Edwin G. Marshall, CEO
           






















                                      3


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission